BridgeMD
OmaMig Pilot
EU CTIS ID: 2025-522448-41-00
What this study is testing
Evaluate the potential clinical benefit on monthly migraine days.
- Therapeutic exploratory (Phase II)
A plain-language read of the study's public EU CTIS listing. The study team confirms the details.
Who can take part
You may be able to join if
- Adults with episodic migraine and 4–14 migraine days pr month with or without aura according to the International Classification of Headache Disorders (ICHD-3)
You likely can't join if
- Use of other migraine preventives during the study.
- Interval headache not distinguishable from migraine.
- Having tried ≥ 3 prophylactic drugs against migraine during the last 10 years.
- Breastfeeding or pregnancy
The study team makes the final eligibility decision.
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18-64 years. The study team makes the final eligibility decision.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from EU CTIS; the study team decides eligibility.